<DOC>
	<DOCNO>NCT01338766</DOCNO>
	<brief_summary>The purpose study evaluate clinical performance decompression use FDA clear iO-Flex® System on-label treating patient spinal stenosis stable grade I degenerative lumbar spondylolisthesis use precision estimate assume 55 % positive response rate .</brief_summary>
	<brief_title>Spondylolisthesis Treated With iO-Flex® System Enabled Decompression</brief_title>
	<detailed_description>This prospective , non-randomized , multi-center ( 30 site ) control clinical study enrol 100 subject follow pre-specified protocol site enrol 30 subject . All eligible subject provide write informed consent meeting study eligibility criterion receive facet preserve decompression use FDA clear iO-Flex® system label . Treatment success use iO-Flex® System analyze use precision estimate assume 55 % positive response rate . In addition baseline characteristic procedural parameter , subject outcome assess 6 week , 6- , 12- , 24 month . The study extend follow-up phase annual follow-up contact 5 year evaluate retreatment original indication late time point .</detailed_description>
	<mesh_term>Radiculopathy</mesh_term>
	<mesh_term>Spondylolisthesis</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<criteria>1 . Adult ( &gt; 18 year age ) 2 . Leg/buttock pain , without back pain 3 . Grade 1 degenerative spondylolisthesis ( ≤25 % slippage ) 4 . NRS pain score leg pain 4/10 great 5 . ODI score 30/100 great 6 . Failed nonoperative medical management period least 6 month 7 . Confirmed clinical diagnosis lumbar spinal stenosis 8 . Confirmation central and/or lateral recess stenosis without foraminal stenosis , one level two adjacent level L2S1 , concordant symptom . Subjects central and/or lateral recess stenosis spondylolisthesis one level , may symptomatic central , lateral recess foraminal stenosis treat one adjacent level . A `` belowthe pedicle '' pas decompress third segment complete provided laminotomies perform 2 level . Subjects , follow intraoperative decision , 3level laminotomy decompression consider enrol . Confirmation spinal stenosis show MRI CT scan evidence nerve root impingement ( displacement compression ) either osseous nonosseous element . 9 . Ability give voluntary , write informed consent participate clinical investigation ability participate follow examination complete patient questionnaires 1 . Back pain 2 . Diagnosis moderate severe peripheral neuropathy diabetic idiopathic peripheral neuropathy , EMG/NCS Neurologist . 3 . History pathologic fracture vertebrae 4 . Primary disc pathology ; plan incidental discectomies NOT exclude long surgeon believe disc pathology primary reason surgical intervention . 5 . Subjects removal midline structure plan , likely result intraoperative decision ; every attempt make spare supraspinous , interspinous facet capsular ligament . 6 . Significant instability lumbar spine define ≥ 4mm translational motion stand lateral view flexion extension radiographs 7 . Prior surgery lumbar spine 8 . Spondylolisthesis great grade 1 ( scale 1 4 ) 9 . Spondylolysis ( pars fracture ) level lumbar spine 10 . Degenerative lumbar scoliosis Cobb angle ≥ 25° 11 . Vascular claudication low extremity 12 . Cauda equina syndrome 13 . Evidence active ( systemic local ) infection time surgery 14 . Paget 's disease involve segment metastasis vertebra , osteomalacia , metabolic bone disease 15 . Tumor spine malignant tumor except basal cell carcinoma . 16 . Prisoner transient 17 . Any significant psychological disturbance past present , psychotic neurotic could impair consent process ability complete subject selfreport questionnaires 18 . Involved pending litigation spine worker 's compensation relate back 19 . Inability communicate clearly English language 20 . Morbid obesity ( BMI &gt; 40 ) 21 . Pregnant , nursing , plan become pregnant . 22 . History narcotic abuse 23 . Current involvement another drug device clinical trial 24 . Uncontrolled diabetes 25 . Irreversible coagulopathy bleed disorder ( patient anticoagulant therapy may participate . Investigators follow routine practice perioperative discontinuation reinitiation anticoagulant . ) 26 . Plans relocate next 2 year 27 . Subject unwilling undergo blood transfusion , necessary</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>spondylolisthesis</keyword>
	<keyword>lumbar spinal stenosis</keyword>
</DOC>